Halozyme Therapeutics, Inc. (HALO)

67.44 +0.32 (+0.48%) USD  |  NASDAQ  |  May 18, 16:00
66.83 -0.61 (-0.90%) Pre-Market: 09:19
More

Halozyme Therapeutics EV to EBIT

EV to EBIT Chart

View EV to EBIT for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to EBIT Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to EBIT Range, Past 5 Years

View EV to EBIT Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to EBIT Benchmarks

View EV to EBIT Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
Agenus, Inc. Upgrade
Inovio Pharmaceuticals, Inc. --
Curis, Inc. --
LadRx Corp. --

EV to EBIT Related Metrics

EV to CFO Upgrade
EV to EBITDA Upgrade
EV to Revenues Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade